BioCentury
ARTICLE | Clinical News

Gestodene/ethinyl estradiol patch: Phase III started

May 11, 2009 7:00 AM UTC

This month, Bayer will begin a pair of international Phase III trials in a total of 3,300 women to evaluate the gestodene/ethinyl estradiol patch applied once weekly for 3 weeks, followed by 1 week of...